medigraphic.com
ISSN 0035-0052 (Print)

2007, Number 4

<< Back Next >>

Rev Mex Pediatr 2007; 74 (4)

A case of Alagille’s syndrome

Jiménez JJR, Castellanos RK, Huerta AR, Justiniani CNE, Yáñez LMP, Sierra TA

Language: Spanish
References: 30
Page: 152-157
PDF size: 234.88 Kb.


ABSTRACT

The Alagille´s syndrome is a congenital disease not frequently seen. It is characterized for cholestasis, vertebral abnormalities, heart defects, eye abnormalities and characteristic facial features. Patients shown abnormalities in the cellular differentiation and organogenesis associated to the gene now Jagged 1, located on chromosome 20. Patients have less number of biliar conducts.


REFERENCES

  1. Watson GH, Miller V. Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child 1973 :48(6): 459-66.

  2. Alagille D, Odièvre M, Gautier M, Dommergues JP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development murmur. J Pediatr 1975; 86: 63-71.

  3. Alagille D, Estrada A, Hadchouel M, Gautier M, Dommergues JP. Syndromic paucity of interlobular bile ductus (Alagille syndrome or arterihepatic dysplasia): Review of 80 cases. J Pediatr 1987; 110: 195-200.

  4. Sherlock S. The syndrome of disappearing intrahepatic bileducts. Lancet 1987; 2: 493-6.

  5. Spinner NB, Colliton RP, Crosnier C, Krantz ID, Hadchouel M, Meunier-Rotival M. Jagged mutations in Alagille syndrome. Hum Mutat 2001; 17: 18-33.

  6. Wu JY, Rao Y. Fringe: Defining borders by regulating the Notch pathway. Curr Opin Neurobiol 1999; 9: 537-43.

  7. Gray GE, Mann RS, Mitsiadis E, Henrique D, Carcangiu ML, Artavanis-Tsakonas S. Human ligands of the Notch receptor. Am J Pathol 1999; 154: 785-794.

  8. Mitsiadis TA, Regaudiat L, Gridley T. Role of the Notch signalling pathway in tooth morphogenesis. Arch Oral Biol 2005; 50: 137-140.

  9. Balistreri WF, Grand R, Hoofnagle JH, Suchy FJ, Ryckman FC, Perlmutter DH, Sokol RJ. Biliary atresia: current concepts and research directions. Hepatology 1996; 23: 1682-1692.

  10. Mack CL, Sokol RJ. Unraveling the pathogenesis and etiology of biliaiy atresia. Pediatr Res 2005; 57(5 Pt 2): 87R-94R.

  11. Martin SR, Garel L, Alvarez F. Alagille’s syndrome associated with cystic renal disease. Arch Dis Child 1996; 74(3): 232-5.

  12. Lardelli M, Dahlstrand J, Lendahl U. The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech Dev 1994; 46: 123-136

  13. Zhang F, Deleuze JF, Aurias A, Dutrillaux AM, Hugon RN, Alagille D et al. Interstitial deletion of the short arm of chromosome 20 in arteriohepatic dysplasia (Alagille syndrome). J Pediatr 1990; 116: 73-77.

  14. Krantz ID, Colliton RP, Genin A et al. Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. Am J Hum Genet 1998; 62(6): 1361-9.

  15. Russo PA, Ellis D, Hashida Y. Renal histopathology in Alagille’s syndrome. Pediatr Pathol 1987; 7(5-6): 557-68.

  16. Schneider BL. Genetic cholestasis syndromes. J Pediatr Gastroenterol Nutr 1999; 28: 124-131.

  17. Emerick KM, Rand EB, Goldmuntz E et al. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology 1999; 29: 822-829.

  18. Sokol RJ, Heubi JE, Balistreri WF. Intrahepatic “cholestasis facies” is it specific for Alagille syndrome? J Pediatr 1983; 103: 205-208.

  19. Spinner NB, Krantz ID, Binita MC. MBB Alagille syndrome genetests.org 18 May 2006.

  20. Rosenfield NS, Kelley MJ, Jensen PS, Cotlier E, Rosenfield AT, Riely CA. Arteriohepatic dysplasia: Radiologic features of a new syndrome. A J R 1980; 135: 1.217-1.223.

  21. Otte JB, de Ville de Goyet J, Reding R et al. Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: a review. Hepatology 1994; 20(1 Pt 2): 41S-48S.

  22. Li L, Krantz ID, Deng Y et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997; 16(3): 243-51.

  23. Brodsky MC, Cuniff C. Ocular anomalies in the Alagille syndrome (arteriohepatic dysplasia). Ophthalmology 1991; 100: 1767-74.

  24. Hingorani M, Nischal KK, Davies A et al. Ocular abnormalities in Alagille syndrome. Ophthalmology 1999; 106(2): 330-7.

  25. Woolf GM, Vierling JM. Disappearig intrahepatic bile ducts: The syndromes and their mechanisms. Semin Liver Dis 1993; 13: 261-275.

  26. Marcus N, Teckman JH, Perlmutter D. Alpha 1 antitrypsin deficiency: from genotype to childhood disease. J Pediatr Gastroenterol Nutr 1998; 27: 65-74.

  27. Arrese M, Ananthananarayanan M, Suchy FJ. Hepatobiliary transport: molecular mechanisms of development and cholestasis. Pediatr Res 1998; 44: 141-7.

  28. el-Youssef M, Whitington PF. Diagnostic approach to the child with hepatobiliary disease. Semin Liver Dis 1998; 18(3): 195-202.

  29. Quiros-Tejeira RE, Ament ME, Heyman MB et al. Variable morbidity in Alagille syndrome: a review of 43 cases. J Pediatr Gastroenterol Nutr 1999; 29(4): 431-7.

  30. Kamath BM, Spinner NB, Emmerich KM et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 2004; 110: 1354-8.




2020     |     www.medigraphic.com